Search Within

Joachim Yahalom

  1. "Sergio Giralt"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (6)
Groups
  1. Bone Marrow Transplant (20)
  2. Center for Hematologic Malignancies (20)
  3. Department of Medicine (20)
  4. Hematologic Malignancies, Division of (20)
  5. Radiation Oncology, Department of (20)
  6. Survivorship Research (20)

More Groups

People
  1. Sergio Giralt (20)
  2. Miguel-Angel Perales (18)
  3. Gunjan Shah (17)
  4. Michael Scordo (17)
  5. Parastoo Dahi (17)
  6. Brandon Imber (16)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (3)
  6. 2019 (3)

More Years

Publications
  1. Blood (8)
  2. Transplantation and Cellular Therapy (3)
  3. Biology of Blood and Marrow Transplantation (2)
  4. Hematological Oncology (2)
  5. Bone Marrow Transplantation (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Elsevier Inc. (6)
  3. Nature Publishing Group (2)
  4. Wiley Blackwell (2)
  5. American Association for Cancer Research (1)
  6. John Wiley & Sons (1)

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
    Journal Article

    Imber, B. S.; Sadelain, M.; DeSelm, C.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Giralt, S.; Park, J. H.; Sauter, C.; Scordo, M.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
    Journal Article

    Hobbs, G. S.; Kaur, N.; Hilden, P.; Ponce, D.; Cho, C.; Castro-Malaspina, H. R.; Giralt, S.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: Long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease
    Journal Article

    Goldberg, J. D.; Linker, A.; Kuk, D.; Ratan, R.; Jurcic, J.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S.; Hsu, K.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save